Enzo Biochem, Inc.
NYSE:ENZ
Overview | Financials
Company Name | Enzo Biochem, Inc. |
Symbol | ENZ |
Currency | USD |
Price | 0.706 |
Market Cap | 36,900,008 |
Dividend Yield | 0% |
52-week-range | 0.68 - 1.44 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Kara Cannon |
Website | https://www.enzo.com |
An error occurred while fetching data.
About Enzo Biochem, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD